Evolute Fx to treat SVD of Edwards Sapien XT THV 10 years post intial implant

An 84-year-old patient underwent a transcatheter aortic valve replacement (TAVR) in 2013 with an Edwards Sapien XT valve. After 10 years, he presented with progressive heart failure symptoms. Echocardiography revealed severe aortic regurgitation and stenosis of the bioprosthesis, with new left ventricular dysfunction (EF 45%). The patient underwent a valve-in-valve (ViV) procedure using a 29mm Evolute FX valve after predilatation. The new valve was implanted within the old frame, avoiding complications such as coronary obstruction or sinus sequestration. Post-procedure results showed no perivalvular regurgitation and improved valve function.